Surgical management of thymic epithelial tumors.

IF 1.7 4区 医学 Q2 SURGERY Surgery Today Pub Date : 2021-03-01 Epub Date: 2020-07-10 DOI:10.1007/s00595-020-02070-y
Yasushi Shintani, Soichiro Funaki, Naoko Ose, Takashi Kanou, Eriko Fukui, Kenji Kimura, Masato Minami
{"title":"Surgical management of thymic epithelial tumors.","authors":"Yasushi Shintani,&nbsp;Soichiro Funaki,&nbsp;Naoko Ose,&nbsp;Takashi Kanou,&nbsp;Eriko Fukui,&nbsp;Kenji Kimura,&nbsp;Masato Minami","doi":"10.1007/s00595-020-02070-y","DOIUrl":null,"url":null,"abstract":"<p><p>Resection is the mainstay of treatment for thymic epithelial tumors (TETs), with complete removal of the tumor and involved organs being the ultimate aim. The choice of surgical approach plays a major role in defining treatment success, and the optimal choice of method should thus provide an adequate surgical view to achieve complete tumor resection. While median sternotomy is considered the gold standard for access to the mediastinum, several minimally invasive approaches to thymectomy have been described, including video-assisted robotic-assisted thymectomy, although the oncological outcomes of that procedure remain unclear. A multimodal approach incorporating chemotherapy or chemoradiotherapy followed by extended surgery may improve resectability and outcomes for patients with advanced TETs. Surgical debulking is also reportedly acceptable for invasive thymoma because of its potential for achieving favorable outcomes. Re-resection is an acceptable option for patients with recurrent thymoma after initial resection, and repeat resection for recurrent pleural dissemination seems effective. Here, the literature on current clinical practices in the surgical management and treatment of TETs is reviewed.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00595-020-02070-y","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00595-020-02070-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/7/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 6

Abstract

Resection is the mainstay of treatment for thymic epithelial tumors (TETs), with complete removal of the tumor and involved organs being the ultimate aim. The choice of surgical approach plays a major role in defining treatment success, and the optimal choice of method should thus provide an adequate surgical view to achieve complete tumor resection. While median sternotomy is considered the gold standard for access to the mediastinum, several minimally invasive approaches to thymectomy have been described, including video-assisted robotic-assisted thymectomy, although the oncological outcomes of that procedure remain unclear. A multimodal approach incorporating chemotherapy or chemoradiotherapy followed by extended surgery may improve resectability and outcomes for patients with advanced TETs. Surgical debulking is also reportedly acceptable for invasive thymoma because of its potential for achieving favorable outcomes. Re-resection is an acceptable option for patients with recurrent thymoma after initial resection, and repeat resection for recurrent pleural dissemination seems effective. Here, the literature on current clinical practices in the surgical management and treatment of TETs is reviewed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胸腺上皮肿瘤的外科治疗。
切除是胸腺上皮肿瘤(TETs)治疗的主要方法,最终目的是完全切除肿瘤和受累器官。手术入路的选择在确定治疗成功方面起着重要作用,因此,最佳的手术入路选择应提供足够的手术视野,以实现肿瘤的完全切除。虽然胸骨正中切开术被认为是进入纵隔的金标准,但已经描述了几种微创胸腺切除术方法,包括视频辅助机器人辅助胸腺切除术,尽管该手术的肿瘤学结果尚不清楚。结合化疗或放化疗后延长手术的多模式方法可以改善晚期tet患者的可切除性和预后。据报道,对于侵袭性胸腺瘤,手术切除也是可以接受的,因为它有可能获得良好的结果。对于初次切除后复发的胸腺瘤患者,再次切除是一种可接受的选择,对于复发性胸膜播散重复切除似乎是有效的。在这里,文献对目前临床实践的外科管理和治疗的TETs进行了回顾。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Surgery Today
Surgery Today 医学-外科
CiteScore
4.90
自引率
4.00%
发文量
208
审稿时长
1 months
期刊介绍: Surgery Today is the official journal of the Japan Surgical Society. The main purpose of the journal is to provide a place for the publication of high-quality papers documenting recent advances and new developments in all fields of surgery, both clinical and experimental. The journal welcomes original papers, review articles, and short communications, as well as short technical reports("How to do it"). The "How to do it" section will includes short articles on methods or techniques recommended for practical surgery. Papers submitted to the journal are reviewed by an international editorial board. Field of interest: All fields of surgery.
期刊最新文献
Is the use of direct oral anticoagulants after non-cardiac thoracic surgery safe for patients? Anemia rates after one-anastomosis gastric bypass versus sleeve gastrectomy: a retrospective cohort study. Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery. Simple pelvimetry predicts the pelvic manipulation time in robot-assisted low and ultra-low anterior resection for rectal cancer. Development of a laparoscopic sigmoidectomy simulator: Sigmaster.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1